The Patent Finder

Compounds and Compositions for Intracellular Delivery of Therapeutic Agents

ModernaTX, Inc.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 10 of these applications claim priority to application PCT/US2016/052352, filed Sep 16, 2016. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresPatent lifetimeUsedRemainingConfidence
US 9,867,888Compounds and Compositions for Intracellular Delivery of Therapeutic Agents
In force
 · High confidence
UsedRemaining
ModernaTX, Inc.In forceHigh confidence
US 9,868,691Compounds and Compositions for Intracellular Delivery of Therapeutic Agents
In force
 · High confidence
ModernaTX, Inc.In forceHigh confidence
US 9,868,692Compounds and Compositions for Intracellular Delivery of Therapeutic Agents
In force
 · High confidence
ModernaTX, Inc.In forceHigh confidence
US 9,868,693Compounds and Compositions for Intracellular Delivery of Therapeutic Agents
In force
 · High confidence
ModernaTX, Inc.In forceHigh confidence
US 10,266,485Compounds and Compositions for Intracellular Delivery of Therapeutic Agents
In force
 · High confidence
ModernaTX, Inc.In forceHigh confidence
US 10,392,341Compounds and Compositions for Intracellular Delivery of Therapeutic Agents
In force
 · High confidence
ModernaTX, Inc.In forceHigh confidence
US 10,442,756Compounds and Compositions for Intracellular Delivery of Therapeutic Agents
In force
 · High confidence
ModernaTX, Inc.In forceHigh confidence
US 12,151,995Compounds and Compositions for Intracellular Delivery of Therapeutic Agents
In force
 · High confidence
ModernaTX, Inc.In forceHigh confidence
US 12,404,232Compounds and Compositions for Intracellular Delivery of Therapeutic Agents
In force
 · High confidence
ModernaTX, Inc.In forceHigh confidence
US 11,220,476Compounds and Compositions for Intracellular Delivery of Therapeutic Agents
In force
 · High confidence
ModernaTX, Inc.In forceHigh confidence
1 more record in this group · Pro
10 of 11 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Pro members see all 11.
Upgrade to Pro
10 of these are in force and held by ModernaTX, Inc..
Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited